Delivery Order SPE2DR25D3004-SPE2DR26FXRM2
- Not listed
- The Defense Logistics Agency awarded a $10,626.56 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 15, 2025, with completion expected by December 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for Act-O-Vials on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.15 to AmerisourceBergen Drug Corp for Act-O-Vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $2,656.66 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $5,100.66 to AmerisourceBergen Drug Corp for Act-O-Vials on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. Performance will occur at the contractor's Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.60 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.10 to AmerisourceBergen Drug Corp for Act-O-Vials on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the company's corporate office in Conshohocken, Pennsylvania, the same location that serves as the...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRM2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,232.77 to AmerisourceBergen Drug Corp for Act-O-Vials on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. As a critical vendor in the DLA Medical Supply Chain, the company delivers medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Act-O-Vials—sterile vials used in pharmaceutical packaging and administration—aligns with AmerisourceBergen's established role in fulfilling medical supply requirements for Defense Health Agency and other federal healthcare systems through competitive, firm fixed-price contracting arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 12/21/25 |